Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
(Most of the reform was ultimately abandoned after a series of successful court challenges, of which Novo Nordisk Canada was a party.) Thomas Digby, a B.C.-based intellectual-property lawyer and chair of the review board from 2023 to 2025, said that if its true that Novo abandoned its Ozempic/Wegovy patent in order to avoid PMPRB review, choosing instead to face generic entry, then its completely unprecedented in my experience, and quite possibly a strategic business mistake. Patent protections will lapse in India and Brazil in March, and in China and Turkey later in the year
Schedule an Appointment If you're among the many who have experienced a change in your facial appearance after taking Ozempic, don't resign yourself to looking older than your years
Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia
FDA may be more cautious with a novel receptor combination, and the unresolved TRIUMPH-3 MACE question could invite additional review time
